Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128620) titled 'An AI-Based Decision Support System for Precision Management of Pancreatic Cystic Neoplasms: A Prospective, Multicenter, Randomized Controlled Trial' on July 23.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Changhai Hospital,The Navy Military Medical University
Condition:
Pancreatic Cystic Neoplasms
Intervention:
AI-assisted decision-making group:Patients will receive AI-assisted clinical management in addition to conventional assessment. Physicians will evaluate patients based on clinical history, laboratory findings, imaging characteristics, and current guidelines, while incorp...